| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 0.99 | 0.59 | 0.44 | 0.11 | 0.03 |
| Other Income | 0.01 | 0.03 | 0.08 | 0.16 | 0.07 |
| Stock Adjustments | 0 | 0 | 0 | 0 | 0 |
| Total Income | 1 | 0.62 | 0.52 | 0.27 | 0.1 |
| EXPENDITURE : | |||||
| Raw Materials | 0 | 0 | 0 | 0.07 | 0.01 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0.05 | 0.01 | 0.01 | 0.04 | 0 |
| Other Manufacturing Expenses | 0.1 | 0.05 | 0.12 | 0 | 0 |
| Employee Cost | 0.27 | 0.34 | 0.25 | 0.13 | 0.03 |
| Selling and Administration Expenses | 0.14 | 0.09 | 0.1 | 0.25 | 0.06 |
| Miscellaneous Expenses | 0.01 | 0 | 0.07 | 0.05 | 0.01 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | 0.43 | 0.13 | -0.03 | -0.27 | 0 |
| Interest and Financial Charges | 0 | 0 | 0 | 0.02 | 0 |
| Profit before Depreciation and Tax | 0.43 | 0.13 | -0.03 | -0.29 | 0 |
| Depreciation | 0.19 | 0.08 | 0.04 | 0.05 | 0.01 |
| Profit Before Tax | 0.23 | 0.05 | -0.07 | -0.34 | -0.01 |
| Tax | 0 | 0.02 | 0 | -0.01 | 0 |
| Profit After Tax | 0.23 | 0.03 | -0.07 | -0.33 | -0.01 |
| Adjustment below Net Profit | 0 | 0 | 0 | 0 | 0 |
| P and L Balance brought forward | -0.37 | -0.41 | -0.34 | 0 | 0.01 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -0.14 | -0.37 | -0.41 | -0.34 | 0 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0.76 | 0.11 | 0 | 0 | 0 |
| Book Value | 15.59 | 14.83 | 14.71 | 14.94 | 16.03 |
| Extraordinary Items | 0 | 0.01 | -0.04 | 0 | 0 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
| Reserves and Surplus | 1.71 | 1.47 | 1.44 | 1.51 | 1.84 |
| Total Shareholders Funds | 4.76 | 4.52 | 4.49 | 4.56 | 4.89 |
| Secured Loans | 1.48 | 0 | 0 | 0 | 0 |
| Unsecured Loans | 0.85 | 0.75 | 0.75 | 0.75 | 0.75 |
| Total Debt | 2.33 | 0.75 | 0.75 | 0.75 | 0.75 |
| Total Liabilities | 7.09 | 5.27 | 5.24 | 5.31 | 5.64 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4.7 | 4.32 | 3.75 | 3.25 | 3.15 |
| Less: Accum. Depreciation | 0.39 | 0.2 | 0.12 | 0.08 | 0 |
| Net Block | 4.31 | 4.12 | 3.63 | 3.17 | 3.15 |
| Capital Work in Progress | 0.49 | 0.38 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0.11 | 0.55 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0.12 | 0.03 | 0.07 | 0 | 0 |
| Sundry Debtors | 0.06 | 0.02 | 0 | 0 | 0 |
| Cash and Bank Balance | 0.08 | 0.01 | 0.05 | 0.01 | 0.17 |
| Loans and Advances | 2.13 | 2.11 | 2.28 | 2.75 | 2.57 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 0.05 | 1.37 | 0.77 | 0.72 | 0.79 |
| Provisions | 0.03 | 0.03 | 0.02 | 0.01 | 0 |
| Net Current Assets | 2.31 | 0.77 | 1.61 | 2.03 | 1.95 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 7.11 | 5.27 | 5.24 | 5.31 | 5.65 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
If I had made LUMPSUM investment of ₹ 1,00,000
in Genomic Valley Biotech Ltd
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
